Rosetta Omics
Worldwide, there are more than 20 million new cases of cancer each year. First-line therapies are not always the most effective and there is a strong need to move towards personalized medicine by offering the patients the best treatment as quickly as possible. This will help in increasing the chance or cure. Therefore, there is a need to improve the prediction of the response to treatments to be able to save patient’s lives and reduce the cost of expensive inefficient treatments. Our goal is to unlock the road to precision medicine by using multiomics, spatial data and AI.
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
14
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Rosetta Omics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
Showing 1 of 5 verified contacts
Top roles at Rosetta Omics
5 distinct titles indexed · top 5 shown.
- 1-'
- 1actionnaire wedressfair
- 1advisory board member
- 1founder and ceo
- 1right hand ceo
Sign up to unlock all 5 contacts at Rosetta Omics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Rosetta Omics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.